Calcium in PDB 5cuh: Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4
Enzymatic activity of Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4
All present enzymatic activity of Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4:
3.4.24.35;
Protein crystallography data
The structure of Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4, PDB code: 5cuh
was solved by
L.Tepshi,
L.Vera,
E.Nuti,
L.Rosalia,
A.Rossello,
E.A.Stura,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
40.91 /
1.83
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
74.680,
97.790,
43.490,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
17.3 /
21.4
|
Other elements in 5cuh:
The structure of Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4 also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4
(pdb code 5cuh). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 6 binding sites of Calcium where determined in the
Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4, PDB code: 5cuh:
Jump to Calcium binding site number:
1;
2;
3;
4;
5;
6;
Calcium binding site 1 out
of 6 in 5cuh
Go back to
Calcium Binding Sites List in 5cuh
Calcium binding site 1 out
of 6 in the Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca303
b:10.5
occ:1.00
|
O
|
A:GLN199
|
2.3
|
9.5
|
1.0
|
O
|
A:HOH441
|
2.3
|
8.2
|
1.0
|
O
|
A:ASP165
|
2.3
|
9.2
|
1.0
|
O
|
A:GLY197
|
2.4
|
12.3
|
1.0
|
O
|
A:HOH439
|
2.4
|
10.9
|
1.0
|
OD1
|
A:ASP201
|
2.4
|
9.9
|
1.0
|
CG
|
A:ASP201
|
3.5
|
11.6
|
1.0
|
C
|
A:ASP165
|
3.5
|
8.2
|
1.0
|
C
|
A:GLN199
|
3.5
|
10.9
|
1.0
|
C
|
A:GLY197
|
3.6
|
11.4
|
1.0
|
OD2
|
A:ASP201
|
4.0
|
10.8
|
1.0
|
O
|
A:HOH459
|
4.1
|
10.9
|
1.0
|
C
|
A:ILE198
|
4.1
|
12.7
|
1.0
|
N
|
A:ASP201
|
4.1
|
10.2
|
1.0
|
O
|
A:ALA164
|
4.1
|
11.8
|
1.0
|
O
|
A:ILE198
|
4.2
|
11.8
|
1.0
|
O
|
A:HOH514
|
4.2
|
14.1
|
1.0
|
N
|
A:GLY197
|
4.2
|
10.1
|
1.0
|
CA
|
A:ASP165
|
4.3
|
8.9
|
1.0
|
C
|
A:GLY200
|
4.3
|
10.6
|
1.0
|
N
|
A:GLN199
|
4.3
|
11.5
|
1.0
|
O
|
A:GLY195
|
4.3
|
10.3
|
1.0
|
CA
|
A:GLY200
|
4.4
|
9.7
|
1.0
|
N
|
A:GLY200
|
4.4
|
10.4
|
1.0
|
CA
|
A:GLY197
|
4.4
|
11.1
|
1.0
|
N
|
A:ILE166
|
4.4
|
7.9
|
1.0
|
CA
|
A:GLN199
|
4.5
|
12.6
|
1.0
|
N
|
A:ILE198
|
4.5
|
12.7
|
1.0
|
CA
|
A:ILE198
|
4.6
|
13.1
|
1.0
|
N
|
A:VAL167
|
4.6
|
8.2
|
1.0
|
CA
|
A:ILE166
|
4.6
|
7.9
|
1.0
|
CB
|
A:ASP201
|
4.6
|
10.6
|
1.0
|
O
|
A:HOH458
|
4.6
|
12.2
|
1.0
|
CA
|
A:ASP201
|
4.7
|
10.3
|
1.0
|
C
|
A:PRO196
|
4.7
|
10.9
|
1.0
|
CH2
|
A:TRP116
|
4.7
|
8.7
|
1.0
|
O
|
A:GLY200
|
4.9
|
10.5
|
1.0
|
|
Calcium binding site 2 out
of 6 in 5cuh
Go back to
Calcium Binding Sites List in 5cuh
Calcium binding site 2 out
of 6 in the Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca304
b:29.2
occ:1.00
|
O
|
A:GLU208
|
2.3
|
20.8
|
1.0
|
O
|
A:HOH512
|
2.4
|
30.2
|
1.0
|
O
|
A:ASP206
|
2.4
|
20.0
|
1.0
|
OD1
|
A:ASP206
|
2.5
|
18.9
|
1.0
|
OD2
|
A:ASP131
|
2.6
|
23.5
|
1.0
|
O
|
A:HOH533
|
2.9
|
30.7
|
1.0
|
OD1
|
A:ASP131
|
2.9
|
36.0
|
1.0
|
O
|
A:HOH482
|
2.9
|
31.1
|
1.0
|
CG
|
A:ASP131
|
3.1
|
27.9
|
1.0
|
C
|
A:ASP206
|
3.4
|
19.3
|
1.0
|
CG
|
A:ASP206
|
3.5
|
20.3
|
1.0
|
C
|
A:GLU208
|
3.6
|
22.0
|
1.0
|
CA
|
A:ASP206
|
4.0
|
17.8
|
1.0
|
OG
|
A:SER129
|
4.1
|
20.2
|
1.0
|
CB
|
A:ASP206
|
4.2
|
18.4
|
1.0
|
N
|
A:GLU208
|
4.3
|
20.5
|
1.0
|
OD2
|
A:ASP206
|
4.3
|
21.6
|
1.0
|
CA
|
A:LEU209
|
4.4
|
23.8
|
1.0
|
C
|
A:ASP207
|
4.4
|
24.7
|
1.0
|
CD1
|
A:TRP210
|
4.4
|
14.5
|
1.0
|
N
|
A:LEU209
|
4.4
|
20.3
|
1.0
|
N
|
A:ASP207
|
4.4
|
18.8
|
1.0
|
O
|
A:HOH430
|
4.4
|
22.9
|
1.0
|
O
|
A:HOH524
|
4.5
|
46.0
|
1.0
|
CA
|
A:GLU208
|
4.6
|
21.1
|
1.0
|
CB
|
A:ASP131
|
4.6
|
24.1
|
1.0
|
CA
|
A:ASP207
|
4.6
|
21.9
|
1.0
|
N
|
A:TRP210
|
4.7
|
22.8
|
1.0
|
O
|
A:ASP207
|
4.9
|
26.7
|
1.0
|
NE1
|
A:TRP210
|
5.0
|
13.9
|
1.0
|
|
Calcium binding site 3 out
of 6 in 5cuh
Go back to
Calcium Binding Sites List in 5cuh
Calcium binding site 3 out
of 6 in the Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca305
b:20.2
occ:1.00
|
OE2
|
A:GLU208
|
2.2
|
24.7
|
1.0
|
OD1
|
A:ASP182
|
2.3
|
28.3
|
1.0
|
O
|
A:ASP185
|
2.3
|
29.4
|
1.0
|
O
|
A:GLY183
|
2.3
|
25.5
|
1.0
|
O
|
A:LEU187
|
2.3
|
19.6
|
1.0
|
OD2
|
A:ASP205
|
2.4
|
16.2
|
1.0
|
CG
|
A:ASP205
|
3.4
|
16.4
|
1.0
|
CD
|
A:GLU208
|
3.4
|
22.7
|
1.0
|
C
|
A:ASP185
|
3.5
|
31.1
|
1.0
|
C
|
A:LEU187
|
3.5
|
20.3
|
1.0
|
CG
|
A:ASP182
|
3.5
|
34.5
|
1.0
|
C
|
A:GLY183
|
3.5
|
31.1
|
1.0
|
N
|
A:LEU187
|
3.9
|
22.8
|
1.0
|
CB
|
A:ASP205
|
4.0
|
14.5
|
1.0
|
C
|
A:GLY186
|
4.1
|
24.3
|
1.0
|
N
|
A:ASP185
|
4.1
|
36.0
|
1.0
|
OD2
|
A:ASP182
|
4.2
|
37.1
|
1.0
|
CA
|
A:LEU187
|
4.2
|
21.2
|
1.0
|
C
|
A:LYS184
|
4.2
|
34.9
|
1.0
|
OE1
|
A:GLU208
|
4.3
|
22.4
|
1.0
|
CG
|
A:GLU208
|
4.3
|
20.9
|
1.0
|
N
|
A:GLY183
|
4.3
|
27.6
|
1.0
|
CA
|
A:ASP185
|
4.3
|
31.1
|
1.0
|
OD1
|
A:ASP205
|
4.4
|
14.8
|
1.0
|
N
|
A:ASP182
|
4.4
|
26.5
|
1.0
|
C
|
A:ASP182
|
4.4
|
28.0
|
1.0
|
N
|
A:GLY186
|
4.4
|
27.6
|
1.0
|
CA
|
A:GLY186
|
4.4
|
22.8
|
1.0
|
N
|
A:LYS184
|
4.4
|
30.6
|
1.0
|
O
|
A:GLY186
|
4.5
|
22.0
|
1.0
|
CA
|
A:GLY183
|
4.5
|
26.7
|
1.0
|
N
|
A:LEU188
|
4.5
|
16.5
|
1.0
|
O
|
A:LYS184
|
4.5
|
37.1
|
1.0
|
CA
|
A:LYS184
|
4.5
|
34.3
|
1.0
|
CA
|
A:LEU188
|
4.6
|
14.6
|
1.0
|
CB
|
A:LEU187
|
4.6
|
21.5
|
1.0
|
CB
|
A:ASP182
|
4.7
|
31.8
|
1.0
|
CA
|
A:ASP182
|
4.7
|
28.8
|
1.0
|
O
|
A:ASP182
|
4.8
|
28.4
|
1.0
|
CD2
|
A:LEU188
|
5.0
|
16.4
|
1.0
|
|
Calcium binding site 4 out
of 6 in 5cuh
Go back to
Calcium Binding Sites List in 5cuh
Calcium binding site 4 out
of 6 in the Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca303
b:8.6
occ:1.00
|
O
|
B:HOH436
|
2.3
|
6.8
|
1.0
|
O
|
B:GLN199
|
2.3
|
7.8
|
0.7
|
O
|
B:GLN199
|
2.3
|
8.1
|
0.3
|
O
|
B:ASP165
|
2.3
|
8.3
|
1.0
|
OD1
|
B:ASP201
|
2.3
|
8.0
|
1.0
|
O
|
B:HOH429
|
2.4
|
8.5
|
1.0
|
O
|
B:GLY197
|
2.4
|
10.1
|
1.0
|
CG
|
B:ASP201
|
3.4
|
9.2
|
1.0
|
C
|
B:ASP165
|
3.4
|
7.7
|
1.0
|
C
|
B:GLN199
|
3.5
|
8.6
|
0.3
|
C
|
B:GLN199
|
3.5
|
8.8
|
0.7
|
C
|
B:GLY197
|
3.6
|
9.9
|
1.0
|
OD2
|
B:ASP201
|
3.9
|
9.8
|
1.0
|
O
|
B:HOH426
|
4.0
|
10.7
|
1.0
|
O
|
B:ALA164
|
4.1
|
9.5
|
1.0
|
C
|
B:ILE198
|
4.1
|
10.4
|
1.0
|
N
|
B:ASP201
|
4.1
|
7.7
|
1.0
|
O
|
B:HOH530
|
4.2
|
11.2
|
1.0
|
N
|
B:GLN199
|
4.2
|
9.7
|
0.3
|
N
|
B:GLY197
|
4.2
|
8.5
|
1.0
|
CA
|
B:ASP165
|
4.2
|
8.8
|
1.0
|
N
|
B:GLN199
|
4.2
|
10.1
|
0.7
|
C
|
B:GLY200
|
4.3
|
7.6
|
1.0
|
CA
|
B:GLY200
|
4.3
|
7.9
|
1.0
|
O
|
B:GLY195
|
4.3
|
8.2
|
1.0
|
O
|
B:ILE198
|
4.3
|
9.8
|
1.0
|
N
|
B:GLY200
|
4.4
|
8.1
|
1.0
|
CA
|
B:GLY197
|
4.4
|
9.4
|
1.0
|
N
|
B:ILE166
|
4.5
|
7.2
|
1.0
|
CA
|
B:GLN199
|
4.5
|
9.1
|
0.3
|
CA
|
B:GLN199
|
4.5
|
9.8
|
0.7
|
N
|
B:ILE198
|
4.5
|
10.8
|
1.0
|
CA
|
B:ILE198
|
4.6
|
11.4
|
1.0
|
CB
|
B:ASP201
|
4.6
|
8.0
|
1.0
|
N
|
B:VAL167
|
4.6
|
7.1
|
1.0
|
CA
|
B:ILE166
|
4.6
|
7.1
|
1.0
|
O
|
B:HOH453
|
4.7
|
13.6
|
1.0
|
C
|
B:PRO196
|
4.7
|
9.2
|
1.0
|
CA
|
B:ASP201
|
4.7
|
7.8
|
1.0
|
CH2
|
B:TRP116
|
4.7
|
7.8
|
1.0
|
O
|
B:GLY200
|
4.9
|
7.1
|
1.0
|
|
Calcium binding site 5 out
of 6 in 5cuh
Go back to
Calcium Binding Sites List in 5cuh
Calcium binding site 5 out
of 6 in the Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 5 of Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca304
b:21.2
occ:1.00
|
O
|
B:HOH528
|
2.3
|
23.3
|
1.0
|
O
|
B:GLU208
|
2.4
|
11.3
|
1.0
|
OD2
|
B:ASP131
|
2.4
|
16.6
|
1.0
|
O
|
B:ASP206
|
2.5
|
11.3
|
1.0
|
OD1
|
B:ASP206
|
2.5
|
12.3
|
1.0
|
O
|
B:HOH553
|
2.7
|
31.0
|
1.0
|
OD1
|
B:ASP131
|
3.0
|
17.5
|
1.0
|
CG
|
B:ASP131
|
3.1
|
16.4
|
1.0
|
C
|
B:ASP206
|
3.4
|
11.3
|
1.0
|
CG
|
B:ASP206
|
3.5
|
12.3
|
1.0
|
C
|
B:GLU208
|
3.6
|
11.2
|
1.0
|
OG
|
B:SER129
|
3.9
|
14.6
|
1.0
|
CA
|
B:ASP206
|
3.9
|
10.5
|
1.0
|
CB
|
B:ASP206
|
4.2
|
12.1
|
1.0
|
OD2
|
B:ASP206
|
4.2
|
13.8
|
1.0
|
CD1
|
B:TRP210
|
4.3
|
8.8
|
1.0
|
CA
|
B:LEU209
|
4.3
|
11.2
|
1.0
|
N
|
B:LEU209
|
4.4
|
10.5
|
1.0
|
N
|
B:GLU208
|
4.4
|
11.3
|
1.0
|
N
|
B:ASP207
|
4.5
|
12.3
|
1.0
|
CB
|
B:ASP131
|
4.5
|
14.7
|
1.0
|
O
|
B:HOH428
|
4.5
|
20.0
|
1.0
|
C
|
B:ASP207
|
4.5
|
12.1
|
1.0
|
N
|
B:TRP210
|
4.6
|
9.7
|
1.0
|
CA
|
B:GLU208
|
4.6
|
11.8
|
1.0
|
CA
|
B:ASP207
|
4.8
|
12.0
|
1.0
|
NE1
|
B:TRP210
|
4.9
|
9.0
|
1.0
|
C
|
B:LEU209
|
5.0
|
10.9
|
1.0
|
|
Calcium binding site 6 out
of 6 in 5cuh
Go back to
Calcium Binding Sites List in 5cuh
Calcium binding site 6 out
of 6 in the Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 6 of Crystal Structure Mmp-9 Complexes with A Constrained Hydroxamate Based Inhibitor LT4 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca305
b:13.1
occ:1.00
|
OE2
|
B:GLU208
|
2.2
|
15.5
|
1.0
|
O
|
B:GLY183
|
2.3
|
15.2
|
1.0
|
OD2
|
B:ASP205
|
2.3
|
9.7
|
1.0
|
O
|
B:LEU187
|
2.3
|
10.8
|
1.0
|
OD1
|
B:ASP182
|
2.4
|
14.5
|
1.0
|
O
|
B:ASP185
|
2.5
|
13.8
|
1.0
|
CG
|
B:ASP205
|
3.4
|
8.7
|
1.0
|
CD
|
B:GLU208
|
3.4
|
13.5
|
1.0
|
C
|
B:LEU187
|
3.5
|
11.2
|
1.0
|
C
|
B:GLY183
|
3.5
|
15.8
|
1.0
|
C
|
B:ASP185
|
3.6
|
13.9
|
1.0
|
CG
|
B:ASP182
|
3.6
|
17.2
|
1.0
|
N
|
B:ASP185
|
3.9
|
14.0
|
1.0
|
N
|
B:LEU187
|
3.9
|
13.1
|
1.0
|
CB
|
B:ASP205
|
4.0
|
8.1
|
1.0
|
C
|
B:LYS184
|
4.0
|
14.8
|
0.9
|
C
|
B:LYS184
|
4.1
|
14.2
|
0.1
|
N
|
B:GLY183
|
4.1
|
15.5
|
1.0
|
CA
|
B:LEU187
|
4.2
|
12.3
|
1.0
|
OD2
|
B:ASP182
|
4.2
|
18.0
|
1.0
|
OE1
|
B:GLU208
|
4.2
|
14.6
|
1.0
|
N
|
B:ASP182
|
4.3
|
17.4
|
1.0
|
CA
|
B:ASP185
|
4.3
|
13.5
|
1.0
|
CG
|
B:GLU208
|
4.3
|
13.2
|
1.0
|
C
|
B:GLY186
|
4.3
|
12.8
|
1.0
|
C
|
B:ASP182
|
4.3
|
17.6
|
1.0
|
OD1
|
B:ASP205
|
4.4
|
8.1
|
1.0
|
N
|
B:LYS184
|
4.4
|
14.7
|
0.1
|
N
|
B:LYS184
|
4.4
|
13.5
|
0.9
|
CA
|
B:LYS184
|
4.4
|
14.8
|
0.9
|
CA
|
B:LYS184
|
4.4
|
14.4
|
0.1
|
N
|
B:LEU188
|
4.4
|
9.8
|
1.0
|
O
|
B:LYS184
|
4.5
|
15.1
|
0.9
|
CA
|
B:GLY183
|
4.5
|
15.5
|
1.0
|
O
|
B:LYS184
|
4.6
|
14.4
|
0.1
|
CB
|
B:LEU187
|
4.6
|
12.7
|
1.0
|
CA
|
B:LEU188
|
4.6
|
9.6
|
1.0
|
N
|
B:GLY186
|
4.6
|
14.8
|
1.0
|
O
|
B:ASP182
|
4.7
|
18.8
|
1.0
|
CA
|
B:GLY186
|
4.7
|
14.9
|
1.0
|
CA
|
B:ASP182
|
4.7
|
17.3
|
1.0
|
CB
|
B:ASP182
|
4.8
|
16.6
|
1.0
|
O
|
B:GLY186
|
4.8
|
12.9
|
1.0
|
CD2
|
B:LEU188
|
5.0
|
9.1
|
1.0
|
|
Reference:
C.Camodeca,
E.Nuti,
L.Tepshi,
S.Boero,
T.Tuccinardi,
E.A.Stura,
A.Poggi,
M.R.Zocchi,
A.Rossello.
Discovery of A New Selective Inhibitor of A Disintegrin and Metalloprotease 10 (Adam-10) Able to Reduce the Shedding of NKG2D Ligands in Hodgkin'S Lymphoma Cell Models. Eur.J.Med.Chem. V. 111 193 2016.
ISSN: ISSN 0223-5234
PubMed: 26871660
DOI: 10.1016/J.EJMECH.2016.01.053
Page generated: Sun Jul 14 17:18:27 2024
|